Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T21:01:24.448Z Has data issue: false hasContentIssue false

Olanzapine and tardive dyskinesia

Published online by Cambridge University Press:  03 January 2018

S. W. Woods*
Affiliation:
Department of Psychiatry Yale University School of Medicine, 34 Park Street, Room B38, New Haven, CT 06519, USA
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

References

Beasley, C. M., Dellva, M. A., Tamura, R. N., et al (1999) Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. British Journal of Psychiatry, 174, 2330.CrossRefGoogle ScholarPubMed
Cummings, J. L. & Winning, W. C. (1989) Recognition and differential diagnosis of tardive dyskinesia. International Journal of Psychiatry in Medicine, 19, 133144.Google Scholar
Glazer, W. M., Morgenstern, H. & Doucette, J. T. (1993) Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. Journal of Clinical Psychiatry, 54, 133139.Google Scholar
Munetz, M. R. & Cornes, C. L. (1983) Distinguishing akathisia and tardive dyskinesia: a review of the literature. Journal of Clinical Psychopharmacology, 3, 343350.CrossRefGoogle ScholarPubMed
Schooler, N. R. & Kane, J. M. (1982) Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486487.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.